Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
47,000
Employees47,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
47,000
Employees47,000

LLY Key Statistics

Market cap
816.41B
Market cap816.41B
Price-Earnings ratio
42.67
Price-Earnings ratio42.67
Dividend yield
0.67%
Dividend yield0.67%
Average volume
3.14M
Average volume3.14M
High today
$869.91
High today$869.91
Low today
$834.57
Low today$834.57
Open price
$839.16
Open price$839.16
Volume
5.01M
Volume5.01M
52 Week high
$935.63
52 Week high$935.63
52 Week low
$623.78
52 Week low$623.78

LLY News

TipRanks 1d
Eli Lilly’s Earnings Call: Robust Growth and Strategic Wins

Eli Lilly And Company ((LLY)) has held its Q3 earnings call. Read on for the main highlights of the call. Elevate Your Investing Strategy: Take advantage of Tip...

TipRanks 1d
Eli Lilly Says Weight-Loss Pill a Candidate for Fast-Track Approval

U.S. pharmaceutical company Eli Lilly (LLY) says that the weight-loss pill it is developing should be a candidate for fast-track approval under the U.S. Food an...

TipRanks 1d
Eli Lilly price target raised to $950 from $900 at BofA

BofA raised the firm’s price target on Eli Lilly (LLY) to $950 from $900 and keeps a Buy rating on the shares after the company reported “strong” Q3 total reven...

Analyst ratings

77%

of 31 ratings
Buy
77.4%
Hold
19.4%
Sell
3.2%

More LLY News

Seeking Alpha 2d
Dividend Roundup: Visa, Eli Lilly, Ford, Wells Fargo, and more

This week's dividend activity included increased payouts from Visa (V) and Marathon Petroleum (MRC) as well as declarations from companies such as Eli Lilly LLY...

Dividend Roundup: Visa, Eli Lilly, Ford, Wells Fargo, and more
Benzinga 2d
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain

Healthcare ETFs are quietly feasting on the gains from Wall Street’s latest obsession – the $150 billion obesity-drug boom. As Eli Lilly And Co (NYSE:LLY), Novo...

Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain
Seeking Alpha 2d
Lilly raises 2025 revenue guidance to $63–$63.5B with 54% Q3 growth and major pipeline advances

Earnings Call Insights Lilly raises 2025 revenue guidance to $63–$63.5B with 54% Q3 growth and major pipeline advances Oct. 30, 2025 2:47 PM ET Eli Lilly and Co...

Lilly raises 2025 revenue guidance to $63–$63.5B with 54% Q3 growth and major pipeline advances
Nasdaq 2d
U.S. Stocks Turning In Mixed Performance On Mixed Earnings News

(RTTNews) - After ending the previous session on opposite sides of the unchanged line, the major U.S. stock indexes are turning in another mixed performance dur...

U.S. Stocks Turning In Mixed Performance On Mixed Earnings News
24/7 Wall St. 3d
Eli Lilly Blows Away Q3 Earnings Expectations

Home Investing Eli Lilly Blows Away Q3 Earnings Expectations Investing Eli Lilly Blows Away Q3 Earnings Expectations By Joel South Oct 30, 2025 9:25 am This...

Eli Lilly Blows Away Q3 Earnings Expectations
Benzinga 3d
Mounjaro And Zepbound Power Eli Lilly's 54% Revenue Jump In Q3, Hikes 2025 Forecast

Eli Lilly and Co. (NYSE:LLY) on Thursday reported better-than-expected third-quarter earnings and boosted its annual forecast, sending the stock higher. LLY st...

Mounjaro And Zepbound Power Eli Lilly's 54% Revenue Jump In Q3, Hikes 2025 Forecast
Investor's Business Daily 3d
Eli Lilly Blows Past Expectations On The Back Of Mounjaro, Zepbound

Eli Lilly (LLY) stock jumped early Thursday after the pharma giant reported adjusted earnings of $7.02 per share on $17.6 billion in third-quarter sales. Analy...

Eli Lilly Blows Past Expectations On The Back Of Mounjaro, Zepbound

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.